Appraisal of the extrapancreatic actions of sulfonylureas.
D000273:Adipose Tissue / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001692:Biological Transport; D050260:Carbohydrate Metabolism; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000378:metabolism / Q000502:physiology; D007657:Ketone Bodies / Q000096:biosynthesis; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D009132:Muscles / Q000378:metabolism; D010084:Oxidation-Reduction; D011480:Protease Inhibitors; D014176:Protein Biosynthesis; D013268:Stimulation, Chemical; D014044:Tolbutamide / Q000494:pharmacology; D000637:Transaminases / Q000037:antagonists & inhibitors
D000596:Amino Acids; D007004:Hypoglycemic Agents; D007328:Insulin; D007657:Ketone Bodies; D011480:Protease Inhibitors; D014044:Tolbutamide; D000637:Transaminases; D005947:Glucose